Intensity Therapeutics, Inc. (INTS) stock
INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.08−0.02 (-0.65%)
Close on Nov 13, 2026Market cap $10.06MP/E –Yield –
Intensity Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Intensity Therapeutics's shares outstanding was 3M at Sep 30, 2026. For fiscal 2025 it was 1M, up 143.8% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | +143.8% |
| FY2024 | Dec 31, 2024 | 1M | +61.4% |
| FY2023 | Dec 31, 2023 | 0M | +152.7% |
| FY2022 | Dec 31, 2022 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 3M | +89.2% |
| Q2 FY2026 | Jun 30, 2026 | 3M | +258.6% |
| Q1 FY2026 | Mar 31, 2026 | 3M | +317.5% |
| Q4 FY2025 | Dec 31, 2025 | 2M | +304.5% |
| Q3 FY2025 | Sep 30, 2025 | 2M | +211.8% |
| Q2 FY2025 | Jun 30, 2025 | 1M | +37.6% |
| Q1 FY2025 | Mar 31, 2025 | 1M | +10.7% |
| Q4 FY2024 | Dec 31, 2024 | 1M | +4.6% |
| Q3 FY2024 | Sep 30, 2024 | 1M | +1.1% |
| Q2 FY2024 | Jun 30, 2024 | 1M | +289.9% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +302.0% |
| Q4 FY2023 | Dec 31, 2023 | 1M | +303.7% |
| Q3 FY2023 | Sep 30, 2023 | 1M | +300.6% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +3.1% |
| Q1 FY2023 | Mar 31, 2023 | 0M | – |
| Q4 FY2022 | Dec 31, 2022 | 0M | – |
| Q3 FY2022 | Sep 30, 2022 | 0M | – |
| Q2 FY2022 | Jun 30, 2022 | 0M | – |
See a number that looks wrong?